Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YELLOW II Study
NCT01837823Phase 2Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jul 2013
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in coronary artery disease (CAD), sponsored by Icahn School of Medicine at Mount Sinai. Started Jul 2013; status: completed.
02
Drugs
rosuvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01837823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01837823.